Literature DB >> 15272855

Steric trigger as a mechanism for CB1 cannabinoid receptor activation.

Joong-Youn Shim1, Allyn C Howlett.   

Abstract

To determine the moiety that behaves as the steric trigger to activate the CB(1) cannabinoid receptor, conformational properties of the nonclassical cannabinoid CP55244, one of the most potent CB(1) receptor agonists, were characterized by conformational analysis, rotational barrier calculations, and molecular dynamics (MD) simulations. It was shown from the present MD simulations that the torsion angles phi1 and phi4 of the C3 side chain showed the most dramatic change when compared with the ground-state receptor-bound conformation, indicating that rotation around these torsion angles is responsible for releasing the ligand strain energy. Multiple stages would be involved in the ligand conformational change. As a molecular mechanism for the ligand-induced CB(1) receptor conformational change, we propose that the C3 side chain serves as the steric trigger, while the ACD-ring moiety of CP55244 serves as the plug. Steric clash with helices within the binding pocket would induce microconformational adaptation within the protein. This mechanism would suggest that rotational flexibility in a ligand may be as important a determinant of agonist activity as the pharmacophoric elements that can be identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272855     DOI: 10.1021/ci040040c

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  3 in total

1.  Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

Authors:  Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 2.  Understanding functional residues of the cannabinoid CB1.

Authors:  Joong-Youn Shim
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor.

Authors:  Lea W Padgett; Allyn C Howlett; Joong-Youn Shim
Journal:  J Mol Signal       Date:  2008-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.